AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca enhertu (trastuzumab deruxtecan — direct product sales) — Worldwide product sales ($M) ($M)
Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables
Latest, FY2025
977
Period ended Dec 31, 2025
Change on a year earlier
+79.3%
545 in FY2024
History
5 years
Since FY2021
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Enhertu (trastuzumab deruxtecan — direct product sales) — Worldwide product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 977 | +79.3% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 545 | +108.8% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 261 | +230.4% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 79 | +364.7% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 17 | – | Form 6-K FY2021Q4 Earnings Release ↗ |
Breakdown
What makes up enhertu (trastuzumab deruxtecan — direct product sales) — worldwide product sales ($m)
- Enhertu (trastuzumab deruxtecan — direct product sales) — Worldwide YoY actual (%)79.0% · FY2025
- Enhertu (trastuzumab deruxtecan — direct product sales) — Worldwide YoY CER (%)81.0% · FY2025
- Enhertu (trastuzumab deruxtecan — direct product sales) — US product sales ($M)0 · FY2025
- Enhertu (trastuzumab deruxtecan — direct product sales) — Emerging Markets product sales ($M)668 · FY2025
- Enhertu (trastuzumab deruxtecan — direct product sales) — Europe product sales ($M)207 · FY2025
- Enhertu (trastuzumab deruxtecan — direct product sales) — Established RoW product sales ($M)102 · FY2025
Cite this data
StockData. (2026). AstraZeneca Enhertu (trastuzumab deruxtecan — direct product sales) — Worldwide product sales ($M) ($M), annual FY2021–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med_enhertu_world
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.